نبذة مختصرة : Objective Dengue is a generally self-limited viral disease, considered a public health problem in Mexico. It can be accompanied by laboratory alterations such as neutropenia, lymphopenia and thrombocytopenia. The objective of the study was to evaluate the incidence of hematological alterations in patients with dengue.Methods We retrospectively included 64 patients, including 14 pregnant women, with a diagnosis of dengue at the Hospital Universitario de Monterrey and Civil Nuevo de Guadalajara from January 2014 to December 2017.Results The most common clinical symptom in the general group was headache and retro-ocular pain in 53 patients (83%), while in pregnant patients it was fever in 12 patients (86%). The median platelet count in the general group was 51.4x103/ μl, with thrombocytopenia in 88% of patients, while in pregnant patients it was 141.1 x103/ μl, with thrombocytopenia in 57% of patients (p=0.002). Platelet recovery was achieved in 7 days in the general group and 4.5 days in pregnant patients.Conclusions Contrary to that reported in the literature, pregnant patients had a lower incidence of thrombocytopenia and a higher platelet count at time of diagnosis without impact on maternal mortality or in the course of pregnancy. ; Objetivo El dengue es una enfermedad viral generalmente autolimitada, que en México se considera un problema de salud pública. Puede acompañarse de alteraciones de laboratorio como neutropenia, linfopenia y trombocitopenia. El objetivo del estudio fue evaluar la incidencia de alteraciones hematológicas en pacientes con dengue.Métodos Se incluyeron retrospectivamente 64 pacientes, 14 embarazadas, con diagnóstico de dengue en los Hospitales Universitario de Monterrey y Civil Nuevo de Guadalajara, de enero de 2014 a diciembre de 2017.Resultados El dato clínico más común en el grupo general fue cefalea y dolor retroocular en 53 pacientes (83%), seguido de la fiebre, que se presentó en 12 pacientes embarazadas (86%). La mediana de cuenta plaquetaria en el grupo general fue de ...
Relation: https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/76916/83416; Goldman L, Schafer AI. Tratado de Medicina Interna. Edicion 24. Barcelona, Elsevier; 2017.; Rosso F, Pineda JC, Sanz AM, Cedano JA, Caicedo LA. Transmission of dengue virus from deceased donors to solid organ transplant recipients: case report and literature review. Braz J Infect Dis. 2018; 22(1):63-9. DOI:10.1016/j.bjid.2018.01.001.; Yin X, Zhong X, Pan S. Vertical Transmission of Dengue Infection: The First Putative Case Reported in China. Rev Inst Med Trop Sao Paulo. 2016; 8:58-90. DOI:10.1590/S1678-9946201658090.; Chen LH, Wilson ME. Update on non-vector transmission of dengue: relevant studies with Zika and other flaviviruses. Trop Dis Travel Med Vaccines. 2016;2:15. DOI:10.1186/s40794-016-0032-y.; Centers for Disease Control and Prevention (CDC). Dengue [Internet]. CDC; 2018 [cited 2018 Jul 1]. https://www.cdc.gov/dengue/.; Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504 7.; Organizacón Mundial de la Salud (OMS). Dengue y dengue grave. [Internet]. Geneva: OMS; 2018 [cited 2018 Jul 1].; Torres I, Cortes D, Becker I. Dengue en México: incremento en la población juvenil durante la última década. Bol Med Hosp Infant Mex. 2014; 71(4):196-201. https://bit.ly/37b7NDW.; Simmons CP, Farrar JJ, Nguyen VV, Wills B. Dengue. N Engl Med. 2012; 366(15):1423-32. DOI:10.1056/NEJMra1110265.; Secretaria de Salud. Panorama Epidemiológico de Dengue [internet]. México: Gobierno de México; 2017 [cited 2018 Jul 1]. https://bit.ly/3lgeSYJ.; Centro Nacional de Excelencia Tecnológica en Salud. Guías de Práctica Clínica. Clasificación, diagnóstico y tratamiento integral del dengue. [Internet]. México: Gobierno de México. https://bit.ly/3mqUCEY.; World Health Organization (WHO). Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition [Internet]. Geneva: WHO; 2009 [cited 2019 Jul 27]. https://bit.ly/2JeiRrr.; Gan VC. Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment. Curr Treat Options Infect Dis. 2014; 6(3):208-26. DOI:10.1007/s40506-014-0025-1.; Kuo HJ, Lee IK , Liu JW. Analyses of clinical and laboratory characteristics of dengue adults at their hospital presentations based on the World Health Organization clinical-phase framework: Emphasizing risk of severe dengue in the elderly. J Microbiol Immunol Infect. 2017; S1684-1182(17)30067-1. DOI:10.1016/j.jmii.2016.08.024.; Murillo-Zamora E, Medina-González A, Trujillo-Hernández B, Mendoza-Cano O, Guzmán-Esquivel J, Higareda-Almaraz M, et al. Clinical markers associated with acute laboratory-confirmed Dengue infection: results of a national epidemiological surveillance system. Rev. Salud Pública. (Bogotá) 2018; 19(6):744-8. DOI:10.15446/rsap.v19n6.61823.; Tewari K, Tewari VV, Mehta R. Clinical and Hematological Profile of Patients with Dengue Fever at a Tertiary Care Hospital - An Observational Study. Mediterr J Hematol Infect Dis. 2018;10(1):e2018021. DOI:10.4084/MJHID.2018.021.; Aroor AR, Saya RP, Sharma A, Venkatesh A, Alva R. Clinical Manifestations and Predictors of Thrombocytopenia in Hospitalized Adults with Dengue Fever. N Am J Med Sci. 2015; 7(12):547-52. DOI:10.4103/1947-2714.172841.; Changal KH, Raina AH , Raina A, Raina M, Bashir R , Latief M , et al. Differentiating secondary from primary dengue using IgG to IgM ratio in early dengue: an observational hospital based clinico-serological study from North India. BMC Infect Dis. 2016; 16:715. DOI:10.1186/s12879-016-2053-6.; Rashmi MV, Hamsaveena. Haematological and biochemical markers as predictors of dengue infection. Malays J Pathol. 2015;37:247-51.PMID: 26712670.; Bhaskar E, Sowmya G, Moorthy S, Sundar V. Prevalence, patterns,and factors associated with bleeding tendencies in dengue. J Infect Dev Ctries. 2015; 9(1):105-10. DOI:10.3855/jidc.5031.; Jayanthi HK, Tulasi SK. Correlation study between platelet count, leukocyte count, nonhemorrhagic complications, and duration of hospital stay in dengue fever with thrombocytopenia. J Family Med Prim Care. 2016; 5(1):120-123. DOI:10.4103/2249-4863.184635.; Cabezas C, Fiestas V, García-Mendoza M, Palomino M, Mamani E, Donaires F. Dengue en el Perú: a un cuarto de siglo de su reemergencia. Rev Peru Med Exp Salud Pública. 2015; 32(1):146-56. https://bit.ly/3mfkIuN.; Teixeira LAS, Nogueira FPDS, Nascentes GAN. Prospective study of patients with persistent symptoms of dengue in Brazil. Rev Inst Med Trop Sao Paulo. 2017; 4:e65. DOI:10.1590/S1678-9946201759065.; Jain S, Mittal A, Sharma SK, Upadhyay AD, Pandey RM, Sinha S, et al. Predictors of Dengue-Related Mortality and Disease Severity in a Tertiary Care Center in North India. Open Forum Infect Dis. 2017;4(2):ofx056. DOI:10.1093/ofid/ofx056.; Kidwai AA, Riaz SU, Aatif S, Paracha S. Spontaneous platelet recovery time in primary and secondary dengue infection in a tertiary care hospital. J Pak Med Assoc. 2014; 64(12):1380-3. PMID: 25842582.; Ron-Guerrero CS, López-Flores F, Ron-Magaña AL. Manifestaciones clínicas y de laboratorio relacionadas con la recuperación de las plaquetas en el dengue hemorrágico. Medicina Universitaria. 2010; 12(46):11-7.; Paixao ES, Harron K, Campbell O, Teixeira MG, Costa MDCN, Barreto ML, et al. Dengue in pregnancy and maternal mortality: a cohort analysis using routine data. Sci Rep. 2018; 8(1):9938. DOI:10.1038/s41598-018-28387-w.; Catão Feitoza H, Koifman S, Jorge Koifman R, Saraceni V. Dengue infection during pregnancy and adverse maternal, fetal, and infant health outcomes in Rio Branco, Acre State, Brazil, 2007-2012. Cad Saúde Pública. 2017; 33(5):e00178915. DOI:10.1590/0102-311x00178915.; https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/76916
Processing Request
No Comments.